4

PRIMARY DOCUMENT

Company: Dianthus Therapeutics, Inc. /DE/
Filed: November 1, 2019
Period of Report: November 1, 2019
Accession Number: 0001562180-19-005307

View Document ↗ View on SEC.gov ↗